Focus Partners Wealth Has $2.20 Million Stock Holdings in The Clorox Company $CLX

Key Points

• Focus Partners Wealth increased its stake in The Clorox Company by 34.4% during Q1, now owning 14,936 shares valued at approximately $2.2 million.
• The Clorox Company plans to distribute a quarterly dividend of $1.24 on November 6, resulting in an annualized dividend yield of 4.0%.
• Despite recent earnings reports showing a 4.5% increase in revenue, several analysts have downgraded their price targets for Clorox stock, with the average target price currently at $142.18.

Focus Partners Wealth grew its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 34.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,936 shares of the company's stock after buying an additional 3,824 shares during the quarter. Focus Partners Wealth's holdings in Clorox were worth $2,199,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of CLX. Wood Tarver Financial Group LLC acquired a new stake in shares of Clorox during the 4th quarter worth approximately $31,000. Ransom Advisory Ltd purchased a new position in Clorox in the first quarter worth $35,000. GW&K Investment Management LLC raised its holdings in shares of Clorox by 239.1% in the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock worth $43,000 after purchasing an additional 208 shares during the period. Roble Belko & Company Inc grew its stake in Clorox by 140.7% during the 1st quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock valued at $53,000 after purchasing an additional 211 shares in the last quarter. Finally, IMA Advisory Services Inc. acquired a new position in Clorox during the 1st quarter valued at approximately $58,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Price Performance

Shares of NYSE:CLX traded down $2.21 during trading hours on Friday, hitting $121.91. 5,300,123 shares of the company's stock traded hands, compared to its average volume of 1,766,696. The company's fifty day simple moving average is $124.04 and its two-hundred day simple moving average is $131.40. The company has a market cap of $14.91 billion, a price-to-earnings ratio of 18.70, a price-to-earnings-growth ratio of 1.00 and a beta of 0.52. The Clorox Company has a 52 week low of $116.53 and a 52 week high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. During the same period in the previous year, the company earned $1.82 EPS. The firm's revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, equities analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be given a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a yield of 4.1%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox's dividend payout ratio (DPR) is currently 76.07%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on CLX. UBS Group lowered their price target on Clorox from $150.00 to $134.00 and set a "neutral" rating on the stock in a research report on Thursday, July 17th. Jefferies Financial Group lowered their target price on Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. Wells Fargo & Company dropped their target price on shares of Clorox from $138.00 to $130.00 and set an "equal weight" rating on the stock in a research report on Friday, September 5th. JPMorgan Chase & Co. upped their target price on shares of Clorox from $133.00 to $135.00 and gave the stock a "neutral" rating in a research report on Monday, September 8th. Finally, Morgan Stanley decreased their price objective on shares of Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a research report on Friday, August 1st. One investment analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat, Clorox has an average rating of "Reduce" and a consensus target price of $142.18.

Insiders Place Their Bets

In other news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.57% of the stock is currently owned by corporate insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.